Jack Nathan Medical Net Income
| JNHMF Stock | USD 0.01 0.00 0.00% |
As of the 16th of February 2026, Jack Nathan retains the Standard Deviation of 98.47, market risk adjusted performance of 1.23, and Risk Adjusted Performance of 0.1092. Jack Nathan technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have collected data for eleven technical drivers for Jack Nathan Medical, which can be compared to its competitors. Please check out Jack Nathan Medical market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Jack Nathan is priced fairly, providing market reflects its last-minute price of 0.009 per share. As Jack Nathan Medical appears to be a penny stock we also urge to confirm its information ratio numbers.
Jack Nathan's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Jack Nathan's valuation are provided below:Jack Nathan Medical does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Jack |
Jack Nathan 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Jack Nathan's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Jack Nathan.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Jack Nathan on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Jack Nathan Medical or generate 0.0% return on investment in Jack Nathan over 90 days. Jack Nathan Medical Corp., together with its subsidiaries, operates primary care medical clinics in Walmart Supercentres... More
Jack Nathan Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Jack Nathan's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Jack Nathan Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1224 | |||
| Maximum Drawdown | 800.0 |
Jack Nathan Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jack Nathan's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Jack Nathan's standard deviation. In reality, there are many statistical measures that can use Jack Nathan historical prices to predict the future Jack Nathan's volatility.| Risk Adjusted Performance | 0.1092 | |||
| Jensen Alpha | 11.52 | |||
| Total Risk Alpha | 4.8 | |||
| Treynor Ratio | 1.22 |
Jack Nathan February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1092 | |||
| Market Risk Adjusted Performance | 1.23 | |||
| Mean Deviation | 23.88 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 98.47 | |||
| Variance | 9696.97 | |||
| Information Ratio | 0.1224 | |||
| Jensen Alpha | 11.52 | |||
| Total Risk Alpha | 4.8 | |||
| Treynor Ratio | 1.22 | |||
| Maximum Drawdown | 800.0 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Jack Nathan Medical Backtested Returns
Jack Nathan is out of control given 3 months investment horizon. Jack Nathan Medical holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 13.11% are justified by taking the suggested risk. Use Jack Nathan Medical Standard Deviation of 98.47, risk adjusted performance of 0.1092, and Market Risk Adjusted Performance of 1.23 to evaluate company specific risk that cannot be diversified away. Jack Nathan holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 9.94, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Jack Nathan will likely underperform. Use Jack Nathan Medical variance, as well as the relationship between the skewness and day typical price , to analyze future returns on Jack Nathan Medical.
Auto-correlation | 0.00 |
No correlation between past and present
Jack Nathan Medical has no correlation between past and present. Overlapping area represents the amount of predictability between Jack Nathan time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Jack Nathan Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Jack Nathan price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Jack Nathan Medical reported net income of (7.81 Million). This is 102.29% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The net income for all United States stocks is 101.37% higher than that of the company.
Jack Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jack Nathan's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Jack Nathan could also be used in its relative valuation, which is a method of valuing Jack Nathan by comparing valuation metrics of similar companies.Jack Nathan is currently under evaluation in net income category among its peers.
Jack Fundamentals
| Return On Equity | -1.78 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.30) % | |||
| Current Valuation | 6.84 M | |||
| Shares Outstanding | 84.33 M | |||
| Shares Owned By Insiders | 41.27 % | |||
| Price To Book | 4.55 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 9.64 M | |||
| Gross Profit | 6.66 M | |||
| EBITDA | (7.54 M) | |||
| Net Income | (7.81 M) | |||
| Cash And Equivalents | 816.49 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 106.58 K | |||
| Debt To Equity | 0.88 % | |||
| Current Ratio | 0.47 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (4.34 M) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | -1.43 | |||
| Market Capitalization | 5.68 M | |||
| Total Asset | 8.14 M | |||
| Z Score | 32.8 | |||
| Net Asset | 8.14 M |
About Jack Nathan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jack Nathan Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jack Nathan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jack Nathan Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Jack OTC Stock
Jack Nathan financial ratios help investors to determine whether Jack OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jack with respect to the benefits of owning Jack Nathan security.